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Abstract. Mono- and disaccharides have been shown to stack on top of DNA 
duplexes stabilizing sequences with terminal C–G base pairs. Here we present an 
apolar version of glucose and cellobiose as new capping agents that stack on DNA 
increasing considerably its stability with respect to their natural polyhydroxylated 
mono- and disaccharide DNA conjugates. 
 
 
Non-covalent forces direct molecular interactions between biomolecules and 
their combination and interplay in biology rules life. DNA being the central molecule 
of life also gives the chance to study molecular interactions in aqueous media. 
Aromatic pi–pi stacking interactions have extensively been studied using DNA as a 
model. Both natural1 and non-natural2–4 aromatic bases attached to the 30-end or 
50-end of double stranded DNA have shown enhanced stabilization of DNA 
duplexes, acting as capping agents. These molecular ‘‘caps’’ are usually planar 
aromatic rings of different size and shape that take advantage of pi–pi stacking 
interactions.5–8 The only non-planar compounds described to stack on DNA are 
steroids such as cholic acid which showed a high increase in DNA stability via CH–pi 
interactions.9 Recently, binaphthyl and phenylcyclohexyl nucleosides10,11 with 
nonplanar aromatic bases have been included inside DNA but no data as capping 
entities were reported.  
 
Our group has studied carbohydrate–aromatic stacking interactions using 
carbohydrate oligonucleotide conjugates (COCs) with dangling-ends as a model. 
First, we evaluated monosaccharide–phenyl interactions as a double dangling motif 
at the edge of a duplex of DNA.12 We found that stabilization varies from -0.15 to -
0.40 kcal mol-1 and depends on the number of hydroxyl groups and 
stereochemistry. Recently, we have shown that highly polar carbohydrates can act 
as DNA capping molecules. Sugar stacking is observed for mono- and disaccharides 
on top of C–G or T–A base pairs as the edge of theDNAduplex.13 Nevertheless, 
stabilization of the DNA double helix is only observed with C–G or G–C terminal 
base pairs.  
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Herein, we report the synthesis of oligonucleotides with permethylated mono- 
and disaccharides covalently linked to their 50-end. These apolar carbohydrates act 
as new capping molecules capable of stacking on double-stranded DNA (Fig. 1). 
Permethylated glucose and cellobiose were found to stabilize DNA duplexes much 
more than natural glucose and cellobiose.  
 
Synthesis of the permethylated carbohydrate oligonucleotide conjugates 
started with the preparation of the corresponding permethylated glucose and 
cellobiose phosphoramidite derivatives (5 and 10, respectively) (Scheme 1). 
Glycosylation of the O-benzyl protected ethylene glycol spacer followed by 
deprotection of the acetyl groups yielded intermediate 2. Methylation under 
standard conditions produced compound 3 in good overall yield (70%, 3 steps). 
Further hydrogenation and standard phosphoramidite preparation proceeded 
uneventfully to yield permethylated glucose phosphoramidite 5 (76%, 2 steps). A 
similar synthetic strategy was followed to prepare permethylated cellobiose 
phosphoramidite 10 (48% yield, 5 steps).  
 
Preparation of the apolar saccharide oligonucleotide conjugates was carried 
out by standard solid phase oligonucleotide synthesis using compounds 5 or 10 at 
the last coupling step. Both apolar carbohydrates were attached to self-
complementary sequences CGCGCG, GGCGCC, AGCGCT and TGCGCA. Solutions of 
the COCs were subjected to UV melting analysis and thermodynamic parameters 
were calculated (Table 1).  
 
Conjugates containing permethylated glucose and cellobiose on sequences 
terminated on a C–G base pair (conjugates 15 and 19) increased considerably their 
melting points (7.8 ºC and 8.3 ºC, respectively) over those of the natural control 
sequence 11. 
 
 
 
 
 
 
 
Fig. 1 Schematic drawing of COCs with dangling-ends and details of one of them 
(permethylated glucose stacking on top of a C–G base pair). 
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Scheme 1 Synthesis of permethylated glucose and cellobiose phosphoramidites 5 and 10. 
Reaction conditions: (a) BnOCH2CH2OH, BF3-OEt2, CH2Cl2; (b) Na2CO3, MeOH; (c) MeI, NaH, 
DMF; (d) H2, Pd(OH)2, THF–MeOH; (e) 2-cyanoethyl-N,N’-diisopropylamino-
chlorophosphoramidite, DIEA, CH2Cl2; (f) H2, Pd(OH)2, AcOEt–MeOH. 
 
Table 1. Thermodynamic parameters for COC’s 
 
X-DNA sequencesa,b,c,d Tm
 e/ ºC -∆Hº -∆Sº -∆Gº37 -∆∆Gº37 
X = nonef      
CGCGCG 11 40.9 46.5 123 8.2 -- 
AGCGCT 12 33.5 40.3 107 7.1 -- 
X = glucose-C2f      
CGCGCG 13 44.0 52.1 140 8.7 -0.5 
AGCGCT 14 33.6 37.3 98 7.0 0.1 
X = glc(Me)-C2f      
CGCGCG 15 48.7 55.0 147 9.4 -1.2 
AGCGCT 16 34.5 44.8 121 7.2 -0.2 
X = cellobiose-C2f      
CGCGCG 17 45.9 49.2 130 8.9 -0.7 
AGCGCT 18 34.4 39.1 103 7.1 0.0 
X = cellob(Me)f      
CGCGCG 19 49.2 55.0 146 9.7 -1.5 
AGCGCT 20 37.7 43.9 117 7.7 -0.6 
a –C2– states for –CH2–CH2–OPO2
-–. b Buffer: 10 mM Na phosphate, 1 M NaCl, pH 7.0. c Estimated 
errors are: Tm ± 0.8 ºC and ±6% in ∆Gº. d Units for ∆Hº and ∆Gº are kcal mol-1 and for ∆Sº are cal K-1 
mol-1. e Average value of three experiments measured at 5 µM conc. f From ref. 13. 
 
 
When conjugates with apolar glucose 15 and apolar cellobiose 19 are 
compared with their corresponding natural hydroxylated versions glucose–DNA 
conjugate 13 and cellobiose– DNA conjugate 17, Tm’s are increased by 4.7 ºC and 
3.3 ºC, respectively. A similar trend is observed when ∆G values are compared; 
conjugates 15 and 19 stabilize CGCGCG duplexes by -1.2 and -1.5 kcal mol-1, 
respectively, with respect to unmodified CGCGCG. This stabilization is similar to that 
found for a benzene nucleoside in the same context.2 As a result, the duplex 
stabilizations of conjugates with the apolar version of glucose 15 and cellobiose 19 
are 2.4 and 2.1 times more stable, respectively, than their corresponding 
conjugates with natural glucose 13 and cellobiose 17. The smaller increase in 
cellobiose may be due to the fact that the increased surface of the apolar version of 
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cellobiose could be too large to fully stack on top of the C–G base pair. Similar 
results were found when the apolar sugars were attached to the GGCGCC sequence 
(see ESIz, Table S3).  
 
In the case of the AGCGCT sequence, both conjugates with permethylated 
glucose 16 and cellobiose 20 show an increase in Tm (1 ºC and 4.2 ºC, respectively) 
and in free energy (-0.1 and -0.6 kcal mol-1, respectively) with respect to the 
natural sequence 12. Once again, similar results were found when the apolar 
carbohydrates were attached to the TGCGCA sequence (see Table S3, ESI). This 
decrease of COC stabilization on sequences with A–T or T–A base pairs at the edge 
of the duplex with respect to the sequences with C–G or G–C base pairs was also 
observed for COCs with the natural mono- and disaccharides. This effect may be 
due to the larger entropy cost of reducing the fraying in the more flexible terminal 
A–T base pair that counteracts the stabilization obtained with the stacking of the 
apolar sugar.13  
 
The structures of the conjugates containing the permethylated glucose unit 
15 and 16 were studied by NMR spectroscopy. Proton assignment was carried out 
following standard procedures. The DNA duplex structures are barely distorted by 
the presence of the apolar sugars as can be inferred by comparison of the DNA 
chemical shifts of the conjugates and the control sequences (see ESI, Fig. S2). 
Chemical shift changes are mostly observed in the neighboring residues of the 
permethylated glucose (C1 in the CGCGCG sequence and A1 in the AGCGCT 
sequence), indicating that the carbohydrate is interacting mainly with the terminal 
residues. This capping interaction is also supported by a significant number of NOEs 
(see Fig. 2 and Table S2, in ESI). The number and intensities of these NOE contacts 
are comparable with those observed in the disaccharide conjugates studied in our 
previous work.13 Strong and medium NOEs are observed between several protons of 
the terminal base-pairs with H3 and H5 of the apolar glucose unit, suggesting that 
the permethylated glucose interacts with the terminal base-pair of the duplex 
predominantly through its a face. In the case of conjugate 16 some low intensity 
NOEs are also observed with H4 proton. These NOEs may arise from spin-diffusion 
or from minor species with different carbohydrate conformations, and were not used 
in the structural calculations. Interestingly, many of the DNA-permethylated glucose 
NOEs involve exchangeable protons of the terminal base-pair. In both conjugates, 
these protons exhibit narrow signals, indicating that they are protected from water 
exchange. As in the case of the natural disaccharide–DNA conjugates studied 
previously, the capping carbohydrate reduces strongly the internal dynamics of the 
terminal base-pairs. This effect is especially pronounced in conjugate 16, where the 
terminal base-pair is AT.  
 
Restrained molecular dynamics calculations were carried out with the AMBER 
program. Resulting structures are shown in Fig. 3. In both conjugates 15 and 16, 
the carbohydrate and the linker adopt a similar and well-defined structure. 
Permethylated glucoses stack on top of the terminal base-pair, with their α sides 
oriented towards the nucleobases. Carbohydrate conformation is the usual 4C1 chair. 
Permethylation increases the carbohydrate size and allows for an enhanced stacking 
interaction in which a single monosaccharide covers most of the terminal base-pair 
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surface (Fig. 3). Although the main features of both conjugates are quite similar, 
minor differences are observed (see Fig. 3, top). These differences are probably due 
to the different adjacent nucleobase, purine in the case of conjugate 15 and 
pyrimidine for 16. 
 
 
 
 
Fig. 2 (a) Schematic drawing of conjugate 16 with arrows indicating important observed 
NOEs; (b) selected region of NOESY spectra for conjugate 16 (carbohydrate–DNA contacts 
are shown in cyan). 
 
 
These results are noteworthy since hydrophobic mono- and disaccharides 
attached to DNA show a relevant increase in stabilization of DNA duplexes especially 
with terminal C–G or G–C base pairs. In this context, the stability of DNA with 
apolar sugars 5’-caps is approaching to that found with the traditional aromatic 
caps. Further improvement may be obtained modulating the hydrophobicity of the 
carbohydrate. NMR studies confirmed that permethylated sugars stack on top of 
duplex DNA similarly to other aromatic moieties. Finally, our results have 
implications in molecular recognition and may be useful in drug design and in the 
assembly of supramolecular structures. 
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Fig. 3 Structures of conjugate 15 (A), and conjugate 16 (B). Top: details of the stacking. 
Bottom: superposition of ten calculated structures. 
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Table S1: NMR proton assignments of carbohydrate oligonucleotide conjugates 15 and 16 (5 ºC). 
 
 
 
Conjugate 15: Glc(Me)-C2-CGCGCG 
 
 H1’ H2’/H2” H3’ H4’ H5’/H5” H5 H6/H8 H1/H3 H41/H42 
C1 5.40 2.35/2.46 4.85 4.12 3.97/3.91 5.97 7.72 -- 7.35/8.64 
G2 5.97 2.75  4.38 4.03/4.13 -- 8.00 13.19 -- 
C3 5.77 2.11/2.47 4.91 4.24 4.06/4.14 5.48 7.42 -- 6.62/8.49 
G4 5.96 2.68/2.77  4.40 4.06/4.14 -- 7.97 13.14 -- 
C5 5.75 1.73/2.23 4.83 4.13 4.07/4.24 5.53 7.36 -- 6.81/8.57 
G6 6.22 2.75/2.38 4.73 4.24 4.06 -- 8.02 13.30 -- 
 LH1a/H1b LH2a/H2b H1 H2 H3 H4 H5 H6a/H6b Met 
glc 3.83/3.93 3.70/3.56 3.97 2.80 2.98 2.91 2.98 3.35/3.23 3.42 
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Conjugate 16: Glc(Me)-C2-AGCGCT 
 
 H1’ H2’/H2” H3’ H4’ H5’/H5” H5/H2 H6/H8 H1/H3 H41/H42 
A1 6.01 2.94/2.92 4.85 4.32 3.84/3.98 8.04 8.29 -- -- 
G2 5.80 2.63  4.41 4.17 -- 7.83 12.91 -- 
C3 5.82 2.09/2.47 4.90 4.25 4.17 5.36 7.38 -- 6.46/8.30 
G4 5.99 2.79/2.71 4.80 4.42 4.07 -- 7.97 13.08 -- 
C5 6.07 2.08/2.52 4.80 4.21 4.07 5.50 7.51 -- 6.85/8.42 
T6 6.34 2.37/2.25 4.64 4.07 4.20 1.76-Me 7.62 -- -- 
 LH1a/H1b LH2a/H2b H1 H2 H3 H4 H5 H6a/H6b Met 
glc 3.62/3.47 3.12 3.45 2.62 2.76 2.85 2.69 3.22/3.37 3.22 
 
Control 12: AGCGCT 
 
 H1’ H2’/H2” H3’ H4’ H5’/H5” H5/H2 H6/H8 H1/H3 H41/H42 
A1 5.98 2.54/2.70 4.86 4.23 3.71  8.07   
G2 5.83 2.70  4.41 4.13/4.24  7.91 12.97  
C3 5.80 2.08/2.45 4.88 4.24 4.08/4.17 5.38 7.38  6.50/8.32 
G4 5.97 2.78/2.69  4.41 4.08/4.19  7.96 13.07  
C5 6.13 2.26/2.52 4.80 4.26 4.08/4.20 5.52 7.52  6.82/8.41 
T6 6.30 2.31 4.20 4.09 4.23 1.77-Me 7.61   
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Table S2: Structurally relevant carbohydrate-DNA NOE contacts for the carbohydrate 
oligonucleotide conjugates glc(Me)-C2-CGCGCG 15 and glc(Me)-C2-AGCGCT 16. (Strong 
NOE: s, medium NOE: m, weak NOE: w, very weak NOE: vw). 
 
15 
Carb Linker 
C1H5-H3/GlcH5: w 
C1H4’-GlcMe: s 
C1H4’-GlcH3/H5: w 
C1H1’-GlcH3/H5: vw 
C1H41-GlcH3: w 
C1H42-GlcH3: w 
C1H42-GlcMe: w 
C1H5-LH2’: s 
C1H5-LH1’: m 
C1H6-LH2’: m 
C1H6-LH1’: m 
C1H4’-LH2’: vw 
 
*G6H8-GlcH3/H5: m 
G6H1’-GlcMe: s 
*G6H1’-GlcH3/H5: m/s 
G6H3-GlcH3: s 
G6H3-GlcMe: vw 
 
 
 
 
 
 
 
 
 
 
16 
Carb Linker 
A1H2-GlcMe: m 
A1H2-GlcH6a: m 
A1H2-GlcH6b: m 
A1H2-GlcH1: w 
A1H2-GlcH3: m 
*A1H2-GlcH4: w 
A1H2-GlcH5: m 
A1H8-GlcMe: w 
A1H8-GlcH1: m 
*A1H8-GlcH2: w 
A1H8-LH1’a: s 
A1H8-LH1’b: s 
A1H8-LH2’: m 
A1H5’/H5’’- LH2’: w 
A1H4’-GlcMe: w 
 
 
T6Me-GlcH6a: w 
T6Me-GlcH6b: m 
T6H6-GlcMe: m 
T6H6-GlcH6a: w 
T6H6-GlcH6b: w 
T6H1’-GlcMe: w 
T6H1’-GlcH6a: w 
T6H1’-GlcH6b: m 
T6H2’/H2’’-GlcH6a: m 
T6H2’/H2’’-GlcH6b: m 
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*Not used in structure calculations 
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Figure S1: Schematic drawings of conjugates 15 and 16 indicating relevant 
carbohydrate-DNA NOEs. 
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Figure S2: Changes in proton chemical shifts along the sequence for the carbohydrate-
oligonucleotide conjugates 15 and 16 with respect to DNA controls 11 and 12, 
respectively. 
 
Conjugate 15: glc(Me)-C2-CGCGCG. 
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Conjugate 16: glc(Me)-C2-AGCGCT. 
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Figure S3: Melting curves for: Glc(Me)-C2- CGCGCG 15 and Glc(Me)-C2- AGCGCT 16. 
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Figure S4: Van’t Hoff curves for DNA controls 11 and 12 and for DNA carbohydrate-
oligonucleotide conjugates 13, 14, 15, 16, 17, 18, 19, 25, 26, 29 and 30. 
 
DNA control 11: CGCGCG (), conjugate 13: glc-C2-CGCGCG () and conjugate 15: 
glc(Me)-C2-CGCGCG (). 
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DNA control 12: AGCGCT (), conjugate 14: glc-C2-AGCGCT () and conjugate 16: 
glc(Me)-C2-AGCGCT (). 
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DNA control 11: CGCGCG (), conjugate 17: cellob-C2-CGCGCG () and 19: 
cellob(Me)C2-CGCGCG (). 
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DNA control 12: AGCGCT (), conjugate 18: cellob-C2-AGCGCT () and conjugate 
20: cellob(Me)-C2-AGCGCT (). 
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 Conjugate 25: glc(Me)-C2-GGCGCC () and conjugate 29: glc(Me)-C2-GGCGCC 
(). 
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Conjugate 26: glc(Me)-C2-TGCGCA (•) and conjugate 30: cellob(Me)C2-TGCGCA 
(). 
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 Table S3: Tm’s and thermodynamic data for COCs 23 to 30 and their corresponding 
controls 21 and 22. 
 
X-DNA sequence 
a,b,c,d
 
Tm 
(ºC) e 
−∆H º  −∆S º  −∆G37  
 
∆∆ G37 º  
X= none f      
GGCGCC     21 37.6 45.6 122 7.8 - 
TGCGCA     22 34.8 37.8 99 7.2 - 
X=glucose-C2 f      
GGCGCC     23 42.2 46.7 124 8.3 -0.5 
TGCGCA     24 34.2 47.8 131 7.2 0.0 
X=glc(Me)-C2      
GGCGCC     25 48.7 53.5 142 -9.5 -1.7 
TGCGCA     26 37.4 44.7 119 -7.7 -0.5 
X=cellobiose-C2 f      
GGCGCC     27 44.2 51.9 139 8.7 -0.9 
TGCGCA     28 35.2 43.9 118 7.2 0.0 
X=cellob(Me)-C2      
GGCGCC     29 50.7 54.0 143 -9.6 -1.8 
TGCGCA     30 37.6 43.1 114 -7.6 -0.4 
a
 -C2- states for –CH2-CH2-OPO2--. b Buffer: 10 mM Na●phosphate, 
1M NaCl, pH 7.0. c Estimated errors are: Tm ±0.7 °C and ±6% in 
∆G°. d Units for ∆H º and ∆G º are kcal/mol and for ∆S º are 
cal/K.mol. e Average value of three experiments measured at 5 µM 
conc.  f From ref. 6 
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Supplementary Methods 
 
Synthesis. General information. 
All chemicals were obtained from chemical suppliers and used without further 
purification, unless otherwise noted. All reactions were monitored by TLC on precoated 
Silica-Gel 60 plates F254, and detected by heating with Mostain (500 ml of 10% 
H2SO4, 25g of (NH4)6Mo7O24•4H2O, 1g Ce(SO4)2•4H2O). Products were purified by 
flash chromatography with silica gel60 (200-400 mesh).  
NMR spectra were recorded on either a Bruker AVANCE 300 or ARX 400 or Bruker 
Advance DRX 500 MHz [300 or 400 MHz (1H), 75 or 100 (13C), at room temperature 
for solutions in CDCl3, D2O or CD3OD]. Chemical shifts are referred to the solvent 
signal and are expressed in ppm. 2D NMR experiments (COSY, TOCSY, ROESY, and 
HMQC) were carried out when necessary to assign the corresponding signals of the new 
compounds. High resolution FAB (+) mass spectral analyses was obtained on a 
Micromass AutoSpec-Q spectrometer. 
 
Preparation and characterization of compounds 2-5 and 7-10. 
 
2-Benzyloxyethyl-β-D-glucopyranoside (2) 
 
To a solution of the tetraacetyl glucopyranosyl trichloroacetimidate 11 (600 mg, 1.21 
mmol) in anhydrous CH2Cl2 (10 mL) and 2-benzyloxyethanol (520 µL, 3.65 mmol), 
BF3.OEt2 (20 µl, 0.24 mmol) was then added. After stirring at room temperature for 1 h 
under argon atmosphere, NEt3 (0.2 ml) was then added. Solvents were then removed 
and the crude was purified by silica gel column chromathography using as eluent (Hex-
AcOEt, 2:1-2:3) to give the glycosyl derivative as a syrup. This product (560 mg, 1.16 
mmol) was dissolved in dry MeOH (10 mL) and Na2CO3 (40 mg, 0.35 mmol) was then 
added. The reaction mixture was stirred for 1 h and IR-120 was then added to 
neutralize. Solvent was then removed and the crude was purified by silica gel column 
chromathography using as eluent (AcOEt:MeOH, 1:0-1:1) to give 2 (290 mg, 80%, 2 
steps) as a syrup. [α]D20 -16.2 (c 1 in MeOH); 1H NMR (CD3OD, 300 MHz) δ (ppm) 
7.39-7.29 (m, 5 H, Ph), 4.58 (d, 1H, J = 7.7 Hz, H-1), 3.89-3.85 (m, 1H, ), 3.80-3.65 
(m, 4H,), 3.38-3.20 (m, 4H, ), OCH2CH2O-). 13C NMR (CD3OD, 75 MHz) δ (ppm) 
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141.9 (Cq arom), 131.9, 131.7, 131.4 (Carom), 106.9 (C1), 80.5, 80.4, 77.6, 76.8, 74.1, 
73.2, 72.1, 65.3. HRMS (ES+) Calcd. for C15H22NaO7 (M+Na): 337.1263, found; 
337.1264.  
 
2-Benzyloxyethyl 2,3,4,6-tetra-O-methyl-β-D-glucopyranoside (3) 
 
To a solution of compound 2 (600 mg, 1.91 mmol) in anhydrous DMF
 
(10 mL) at 0ºC, 
NaH (275 mg, 11.46 mmol) was added. The reaction mixture was stirred for 10 min and 
MeI (952 µL, 15.28 mmol) was added. After 18 h, 2-propanol was then added dropwise 
and finally NH4Cl sat (50 mL) was also added. The organic phase was extracted with 
ethyl acetate (2x100 mL) and washed with sodium bisulfate solution (50 mL) and brine 
(50 mL). Solvents were then removed and the crude was purified by silica gel column 
chromathography using as eluent (Hex-AcOEt, 2:1-1:2) to give 3 (620 mg, 88%) as a 
syrup. [α]D20 -21.5 (c 1 in CHCl3); 1H NMR (CDCl3, 300 MHz): δ (ppm) 7.26-7.18 (m, 
5 H, Ph), 4.48 (s, 2 H, CH2Ph), 4.21 (d, 1H, J = 7.8 Hz, H1), 3.96-3.93 (m, 1H, 
OCH2CH2OBn), 3.68-3.57 (m, 3H, OCH2CH2OBn), 3.54 (s, 3 H, CH3O), 3.52-3.47 (m, 
5 H, H6, H6’, CH3O), 3.30 (s, 3 H, CH3O), 3.19-3.16 (m, 1 H, H5), 3.08-3.05 (m, 2 H, 
H3, H4), 2.97-2.94 (m, 1H, H2). 13C NMR (CD3OD, 75 MHz) δ (ppm) 138.2 (Cq arom), 
128.4, 127.6, 127.5 (Carom), 103.5 (C1), 86.3(C3), 83.6 (C2), 79.3 (C4), 74.5 (C5), 73.1 
(CH2Ph), 71.3 (C6), 69.2, 68.9 (OCH2), 60.7 , 60.4, 60.3, 59.3 (CH3O). HRMS (ES+) 
Calcd. for C19H30NaO7 (M+Na): 393.1989, found; 393.1880.  
 
2-Hydroxyethyl 2,3,4,6-tetra-O-methyl-β-D-glucopyranoside (4) 
 
A solution of compound 3 (500 mg, 1.349 mmol) in ethyl acetate-MeOH (1:1, 5mL) 
and Pd(OH)2 in catalytic amount was stirred under an atmosphere of hydrogen for 18 h. 
The mixture was filtered off over celite and solvents were removed. The crude was 
purified by silica gel column chromathography using as eluent (Hex-AcOEt, 1:3) to 
give 4 (320 mg, 82%) as a syrup. [α]D20 -2.5 (c 1 in CHCl3); 1H NMR (CDCl3, 300 
MHz): δ (ppm) 4.20 (d, 1H, J = 7.8 Hz, H1), 3.82-3.61 (m, 4H, OCH2CH2OBn), 3.57 (s, 
4 H, H6’, CH3O), 3.51 (s, 3 H, CH3O), 3.49-3.43 (m, 4 H, H6’, CH3O), 3.30 (s, 3 H, 
CH3O), 3.29-3.24 (m, 1 H, H5), 3.13-3.02 (2 t, 2 H, J = 9.0 Hz, H3, H4), 2.94 (t, 1 H, J = 
9.0 Hz, H2). 13C NMR (CDCl3, 75 MHz) δ (ppm); 103.8 (C1), 86.4 (C3), 83.6 (C2), 79.5 
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(C4), 74.1 (C5), 73.4, 71.4, 62.3, 60.7, 60.4, 60.3, 59.2 (CH3O). HRMS (ES+) Calcd. for 
C12H24NaO7 (M+Na): 303.1420, found; 303.1431.  
 
2-(2,3,4,6-Tetra-O-methyl-β-D-glucopyranosyloxy)ethyl (2-cyanoethyl) (N,N-
diisopropyl) phosphoramidite (5) 
 
DIEA (0.695 mL, 4.0 mmol) and 2-cyanoethyl-N, N’-diisopropylamino-
chlorophosphoramidite (334 µL, 1.5 mmoL) were added to a solution of compound 4 
(280 mg, 1.0 mmol) in anhydrous CH2Cl2 (5 mL) at room temperature under an argon 
atmosphere. After 1.0 h no starting material was observed. Solvent was then removed 
and the crude was purified by silica gel column chromatography by using Hex/EtOAc 
(1:1 with 5% of NEt3) to give compound 5 (450 mg, 93%) as a syrup. 1H NMR (CDCl3, 
300 MHz) (mix of isomers) δ (ppm) 4.19 (d, 1H, J =7.8 Hz, H1), 3.93-3.44 (m, 6H, 
OCH2CH2O, OCH2CH2CN), 3.61-3.44 (m, 12 H, 3x CH3O, H6, H6’, 2xCHisopropyl), 3.31 
(s, 3 H, CH3O), 3.18-3.16 (m, 1H, H5), 3.08-3.05 (m, 2 H, H4, H3), 2.93-2.90 (m, 1 H, 
H2), 2.59-2.55 (m, 2 H, -OCH2CH2CN), 1.11 (d, 12H, J=6.5 Hz, 4CH3isopropyl). 13C 
NMR (CDCl3, 75 MHz) δ (ppm); 117.6 (CN), 103.4 (C1), 86.2 (C3), 83.6 (C2), 79.1 
(C4), 74.4 (C5), 71.2, 71.3, 69.3, 62.3, 60.6, 60.3, 60.2, 59.1, 58.3, 42.9, 24.6, 24.5, 24.4, 
20.2. HRMS (ES+) Calcd. for C21H41N2O8PNa (M+Na): 503.2498, found; 503.2483.  
 
2-Benzyloxyethyl 2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-β- D-
glucopyranosyl)-β-D-glucopyranoside (7) 
 
To a solution of the heptaacetyl cellobiose trichloroacetimidate 61 (900 mg, 1.15 mmol) 
in anhydrous CH2Cl2 (10 mL) and 2-benzyloxyethanol (250 µL, 1.72 mmol), BF3.OEt2 
(15 µl, 0.11 mmol) was then added. After stirring at room temperature for 2 h under 
argon atmosphere, NEt3 (0.1 ml) was then added. Solvents were then removed and the 
crude was purified by silica gel column chromathography using as eluent (Hex-AcOEt, 
2:1-2:3) to give 7 (700 mg, 79%) as a syrup. 1H NMR (CDCl3, 300 MHz) δ (ppm) 7.32-
7.28 (m, 5H, Ph), 5.19-5.09 (m, 2H, H3A, H3B), 5.01 (t, 1H, J = 9.6 Hz, H4B), 4.93-4.87 
(m, 2H, H2A, H2B), 4.56 (2d, 2H, J = 7.8 Hz, H1A, H1B), 4.54-4.47 (m, 3H, OCH2, H6A), 
4.35 (dd, 1H, J = 4.5, 12.6 Hz, H6B), 4.10-3.91 (m, 3H, OCH2, H6’A, H6’B), 3.79-3.55 (m, 
6H, OCH2, H5A, H5B, H4A), 2.09-1.96 (6s, 21H. OCOCH3).  13C NMR (CDCl3, 75 MHz) 
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δ (ppm) 170.5, 170. 3, 170.2, 169.8, 169.6, 169.3, 169.0 (C=O), 138.1 (Cqarom), 128.4, 
127.6, 127.5 (Carom), 100.8 (C1A), 100.7 (C1B), 76.4, 73.2, 72.9, 72.6, 72.5, 71.9, 71.6, 
71.5, 69.2, 69.1, 67.8, 61.8, 61.5, 21.0, 20.8, 20.6, 20.5. HRMS (ES+) Calcd. for 
C35H46O19Na (M+Na): 793.2531, found; 793.2520.  
 
2-Benzyloxyethyl 2,3,6-tri-O-methyl-4-O-(2,3,4,6-tetra-O-methyl-β- D-
glucopyranosyl)-β-D-glucopyranoside (8) 
 
Compound 7 (560 mg, 0.72 mmol) was dissolved in dry MeOH (10 mL) and Na2CO3 
(23 mg, 0.21 mmol) was then added. The reaction mixture was stirred for 2 h and IR-
120 was then added to neutralize. Solvent was then removed and the crude was used for 
next step without any further purification. To a solution of the crude (300 mg, 0.62 
mmol) in anhydrous DMF
 
(6 mL) at 0ºC, NaH (151 mg, 6.3 mmol) was added. The 
reaction mixture was stirred for 10 min and MeI (549 µL, 8.81 mmol) was then added. 
After 24 h stirring at room temperature, 2-propanol was then added dropwise and 
NH4Cl sat (25 mL). Organic phase was extracted with ethyl acetate (2x50 mL) and 
washed with sodium bisulfate solution (50 mL) and brine (50 mL). Solvents were then 
removed and the crude was purified by silica gel column chromathography using as 
eluent (Hex-AcOEt, 1:1-1:6) to give 8 (300 mg, 84%) as a syrup. 1H NMR (CDCl3, 300 
MHz) δ (ppm) 7.08-7.03 (m, 5H, Ph), 4.31 (s, 2H, CH2Ph), 4.07 (2d, 2H, J = 7.8 Hz, 
H1A, H1B),  3.81-3.74 (m, 1H, OCH2), 3.52-3.27 (m, 23H, H6A, H6’A, OCH2, H5A H5B, 
5xCH3O), 3.16-3.09 (m, 7H, 2xCH3O, H6B,), 3.03-2.85 (m, 4H, H6’B, H3B, H3A, H4A), 
2.82 (dd, 1H, J = 7.8, 9.0 Hz, H2B), 2.68 (t, 1H, J = 8.7 Hz, H2A). 13C NMR (CDCl3, 75 
MHz) δ (ppm) 139.2 (Cqarom), 129.2, 128.6, 128.5 (Carom), 104.4 (C1A), 104.1 (C1B), 
87.9, 85.4, 85.0, 84.0, 80.3, 78.6, 75.6, 74.1, 72.1, 71.6, 70.3, 69.8, 61.6, 61.5, 61.3, 
61.2, 61.1, 60.2, 60.0. HRMS (ES+) Calcd. for C21H40O12Na (M+Na): 507.2417, found; 
507.2433.  
 
2-Hydroxyethyl 2,3,6-tri-O-methyl-4-O-(2,3,4,6-tetra-O-methyl-β-D-
glucopyranosyl)-β-D-glucopyranoside (9) 
 
A solution of compound 8 (300 mg, 0.52 mmol) in ethyl acetate-MeOH (1:1, 5mL) and 
Pd(OH)2 in catalytic amount was stirred under an atmosphere of hydrogen for 24 h. The 
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mixture was filtered off over celite and solvents were removed. The crude was purified 
by silica gel column chromathography using as eluent (Hex-AcOEt, 1:6→0:1) to give 9 
(209 mg, 83%) as a syrup. 1H NMR (CDCl3, 500 MHz) δ (ppm)  4.24-4.22 (2d, 2H, J = 
7.8 Hz, H1A, H1B),  3.85-3.77 (m, 2H, OCH2), 3.68-3.52 (m, 16H, H6A, H6’A, OCH2,  
H6B, H6’B, H4B, 3xCH3O), 3.49, 3.47 (2s, 6H, 2xCH3O), 3.40-3.38 (m, 1H, H5B), 3.22-
3.06 (m, 5H, H5A, H3B, H3A, H4A, OH), 3.00 (dd, 1H, J = 7.8, 9.0 Hz, H2B), 2.68 (t, 1H, J 
= 8.7 Hz, H2A). 13C NMR (CDCl3, 125 MHz) δ (ppm 103.8 (C1A), 103.1 (C1B), 86.9, 
85.5, 84.0, 83.1, 79.2, 77.9, 74.6, 74.3, 73.4, 71.1, 70.8, 62.3, 60.7, 60.5, 60.4, 60.3, 
60.2, 59.2, 59.0. HRMS (ES+) Calcd. for C21H40O12Na (M+Na): 507.2417, found; 
507.2433.  
 
2-[(2,3,4,6-Tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-
glucopyranosyloxy)]ethyl (2-cyanoethyl) (N,N-diisopropyl) phosphoramidite (10) 
 
 
DIPEA (115 µL, 0.66 mmol) and 2-cyanoethyl-N,N’-diisopropylamino-
chlorophosphoramidite (55 µL, 0.24 mmoL) were added to a solution of compound 9 
(80 mg, 0.16 mmol) in anhydrous CH2Cl2 (3 mL) at room temperature under an argon 
atmosphere. After 1.0 h no starting material was observed. Solvent was then removed 
and the crude was purified by silica gel column chromatography by using Hex/EtOAc 
(1:2 with 5% of NEt3) to give compound 10 (100 mg, 88%) as a syrup. 1H NMR 
(CDCl3, 300 MHz) δ (ppm) 4.25-4.20 (m, 2H, H1A, H1B), 3.95-3.41 (m, 27H, H6A, H6B, 
H6’A, 2xOCH2, OCH2CH2CN, 2xCHisopropyl, H6’B, 5xCH3O), 3.34-3.30 (m, 7H, H5B, 
2xCH3O), 3.22-3.01 (m, 4H, H3A, H3B, H4A, H5A), 2.95 (t, 1H, J = 9.0 Hz, H2B), 2.86 (t, 
1H, J = 9.0 Hz, H2A), 2.22-2.39 (m, 2H, CH2CN), 1.09 (d, 12H, J=6.5 Hz, 4CH3isopropyl). 
13C NMR (CDCl3, 75 MHz) δ (ppm) 117.9 (CN), 103.5 (C1A), 103.1 (C1B), 86.9, 84.3, 
84.0, 83.0, 79.3, 77.5, 74.6, 71.1, 70.5, 69.4, 60.7, 60.6, 60.4, 60.3, 60.2, 59.3, 59.0, 
58.4, 43.0, 24.7, 24.6, 24.5, 20.3. HRMS (ES+) Calcd. for C28H46O12Na (M+Na): 
597.2887, found; 597.2882.  
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Proton and carbon NMR spectra of compounds 2-5 and 7-10. 
 
Compound 2 
 
9 8 7 6 5 4 3 2 1 ppm
 
 
200 180 160 140 120 100 80 60 40 20 0 ppm
 
Compound 3 
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O
OMe
MeO
OMe
O
OBn
MeO
 
 
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
 
 
200 180 160 140 120 100 80 60 40 20 0 ppm
 
 
 
Compound 4 
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0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.5 ppm
 
 
 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
 
 
 
Compound 5 
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10 9 8 7 6 5 4 3 2 1 ppm
 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
Compound 7 
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11 10 9 8 7 6 5 4 3 2 1 ppm
 
 
 
 
200 180 160 140 120 100 80 60 40 20 0 ppm
 
 
Compound 8 
 
 S31 
11 10 9 8 7 6 5 4 3 2 1 0 ppm
 
 
 
200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
Compound 9 
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9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
 
 
 
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
 
 
 
 
Compound 10 
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11 10 9 8 7 6 5 4 3 2 1 0 ppm
 
 
200 180 160 140 120 100 80 60 40 20 0 ppm
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Synthesis of carbohydrate–oligonucleotide conjugates 
 
Carbohydrate-oligonucleotide conjugates 15, 16, 19 and 20 were synthesized on an 
Applied Biosystems 394 synthesizer by using standard β-cyanoethylphosphoramidite 
chemistry. Conjugate 19, 20, 25, 26, 29 and 30 were prepared by Biomers following the 
same methodology. Oligonucleotide conjugates were synthesized either on low-volume 
200 nmols (LV200) or 1.0 µmol scale and using the DMT-off procedure. 
Oligonucleotide supports were treated with 33% aqueous ammonia for 16 h at 55ºC, 
then the ammonia solutions were evaporated to dryness and the conjugates were 
purified by reversed-phase HPLC in a Waters Alliance separation module with a PDA 
detector. HPLC conditions were as follows: Nucleosil 120 C18, 250x8 mm, 10 µm 
column; flow rate: 3 mL/min. A 27 min linear gradient 0-30%B (solvent A: 5% 
CH3CN/ 95% 100 mM triethylammonium acetate (TEAA; pH 6.5); solvent B: 70% 
CH3CN/30% 100 mM TEAA (pH 6.5)). 
 
Thermodynamic measurements 
 
Self-complementary oligonucleotides and COCs were hybridized by heating the sample 
at 90ºC for 3 min and letting cool down to room temperature during 3h. Melting curves 
for the DNA conjugates were measured in a Perkin–Elmer Lambda 750 UV/Vis 
spectrophotometer at 280 nm while the temperature was raised from 10 to 80 ºC at a 
rate of 1.0 ºCmin-1. Curve fits were excellent, with c2 values of 106 or better, and the 
Van’t Hoff linear fits were quite good (r2=0.97) for all oligonucleotides. 
Thermodynamic parameters were calculated from the average values obtained from 
melting curve fitting (using Meltwin software) and linear Van’t Hoff plots of 1/Tm vs ln 
([conjugate]). ∆H, ∆S, and ∆G errors were calculated as described previously.2, 3 
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HPLC chromatograms of carbohydrate oligonucleotide conjugates 15, 16, 18, 19 
and 20.  
 
 
Conjugate glc(Me)-C2-CGCGCG (15)   Conjugate glc(Me)-C2-AGCGCT (16) 
 
    
 
Conjugate cellob(Me)-C2-CGCGCG (19)  Conjugate cellob(Me)-C2-AGCGCT 
(20) 
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Conjugate glc(Me)-C2-GGCGCC (25)   Conjugate glc(Me)-C2-TGCGCA (26) 
 
   
 
Conjugate cellob(Me)-C2-GGCGCC (29)  Conjugate cellob(Me)-C2-TGCGCA 
(30) 
Maldi-TOF mass spectra of carbohydrate oligonucleotide conjugates. 
 
MALDI-TOF spectra were performed using a Perseptive Voyager DETMRP mass 
spectrometer, equipped with nitrogen laser at 337 nm using a 3ns pulse. The matrix 
used contained 2,4,6-trihydroxyacetophenone (THAP, 10 mg/ml in ACN/ water 1:1) 
and ammonium citrate (50 mg/ ml in water). 
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Carbohydrate oligonucleotide 
conjugates [M-H] calc. [M-H] exp. 
β-D-glc(Me)-C2-CGCGCG (15) 2133.5 2133.5 
β-D-glc(Me)-C2-AGCGCT (16) 2132.5 2132.5 
β-D-cellob(Me)-C2-CGCGCG (19) 2338.3 2339.0 
β-D-cellob(Me)-C2-AGCGCT (20) 2337.3 2337.0 
β-D-glc(Me)-C2-GGCGCC (25) 2133.5 2142.0 
β-D-glc(Me)-C2-TGCGCA (26) 2132.5 2140.0 
β-D-cellob(Me)-C2-GGCGCC (29) 2338.3 2344.0 
β-D-cellob(Me)-C2-TGCGCA (30) 2337.3 2342.0 
 
 
NMR spectroscopy and structure calculations. 
 
Samples of the conjugates were purified by HPLC, ion-exchanged with Dowex 50W 
resin and then suspended in 500 µL of either D2O or H2O/D2O 9:1 in phosphate buffer, 
100 mM NaCl, pH 7. NMR spectra were acquired in Bruker Avance spectrometers 
operating at 600 or 800 MHz, and processed with Topspin software. DQF-COSY, 
TOCSY and NOESY (mixing times of 150 and 300ms) experiments were recorded in 
D2O at temperatures ranging from 5 ºC to 25 ºC. NOESY spectra in H2O were acquired 
with 100 ms mixing time at 5 ºC to reduce the exchange with water. The spectral 
analysis program Sparky4 was used for semiautomatic assignment of the NOESY cross-
peaks and quantitative evaluation of the NOE intensities. Distance constraints with their 
corresponding error bounds were incorporated into the AMBER5 potential energy by 
defining a flat-well potential term. Restrained molecular dynamics calculations were 
carried out following protocols described in our previous study.6 The structures were 
refined including explicit solvent, periodic boundary conditions and the Particle-Mesh-
Ewald method to evaluate long-range electrostatic interactions. Force field parameters 
for the carbohydrate moieties were taken from GLYCAM7, and the TIP3P model was 
used to describe water molecules.8 Analysis of the representative structures as well as 
the MD trajectories was carried out with the program MOLMOL9 and the analysis tools 
of AMBER. 
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